Özdemir-van Brunschot Denise M D, Zerellari Romina, Tevs Maria, Wassiljew Sergei, Holzhey David
Department of Vascular Surgery and Endovascular Therapy, Augusta Hospital and Catholic Hospital Group Düsseldorf, 40472 Düsseldorf, Germany.
Faculty of Health, Witten/Herdecke University, 58544 Witten, Germany.
Rev Cardiovasc Med. 2024 Mar 6;25(3):90. doi: 10.31083/j.rcm2503090. eCollection 2024 Mar.
Thoracoabdominal aneurysms and aortic dissections are a challenge for vascular surgeons. Open surgery, fenestrated or branched endograft, and the chimney technique are not possible in some patients, because of comorbidities or anatomical restrictions. However, the multilayer flow modulator (MFM) can be implanted in some of these patients. In this systematic review, we will describe the experience with the multilayer stent. To augment the limited number of studies available, we will include a cohort of patients from our hospital.
We retrieved data on all consecutive patients treated using the MFM between May 2013 and August 2020. This included patients with type B dissections and thoracoabdominal or thoracic aneurysms who were unfit for open surgery. The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included all the studies that used the MFM in the aortic segment. Single-arm meta-analyses were performed using OpenMeta (Brown University, Providence, RI, USA).
A total of 37 patients were treated in our hospital during the study period. The technical success was 97.3% and the 30-day mortality was 5.4%. In 40.5% of the included patients, the instructions for use were not followed. Off-label implantation was associated with a higher aneurysm-related mortality. A total of 12 studies were included in the meta-analysis and the technical success was 97.8%. In 68.5%, the aneurysm sack or false lumen remained perfused, 97% of all the covered side branches remained patent. After a follow-up period of 1 year, five patients in the meta-analysis presented with a ruptured aneurysm.
The overall quality of evidence is poor because long-term results are lacking, patients are frequently lost during follow-up and all the studies were non-comparative. Our retrospective study suggests a relatively low incidence of perioperative complications, although there was a high incidence of persistent perfusion in the aneurysm sac (102 of 149 patients). The risk of rupture at the 1-year follow-up was 2.1%.
胸腹主动脉瘤和主动脉夹层对血管外科医生来说是一项挑战。由于合并症或解剖学限制,一些患者无法进行开放手术、开窗或分支型腔内移植物手术以及烟囱技术。然而,多层血流调节器(MFM)可植入部分此类患者体内。在本系统评价中,我们将描述多层支架的应用经验。为补充现有有限数量的研究,我们将纳入我院的一组患者。
我们检索了2013年5月至2020年8月期间所有使用MFM治疗的连续患者的数据。这包括不适合开放手术的B型夹层患者以及胸腹或胸主动脉瘤患者。系统评价按照系统评价及Meta分析的首选报告项目(PRISMA)指南进行。我们纳入了所有在主动脉段使用MFM的研究。使用OpenMeta(美国罗德岛普罗维登斯布朗大学)进行单臂Meta分析。
研究期间我院共治疗37例患者。技术成功率为97.3%,30天死亡率为5.4%。40.5%的纳入患者未遵循使用说明。超适应证植入与较高的动脉瘤相关死亡率相关。Meta分析共纳入12项研究,技术成功率为97.8%。68.5%的患者动脉瘤囊或假腔仍有血流灌注,所有覆膜侧支血管97%保持通畅。随访1年后,Meta分析中有5例患者出现动脉瘤破裂。
由于缺乏长期结果、随访期间患者经常失访且所有研究均为非对照研究,证据的总体质量较差。我们的回顾性研究表明围手术期并发症发生率相对较低,但动脉瘤囊持续灌注发生率较高(149例患者中有102例)。1年随访时破裂风险为2.1%。